CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis

D Raspadori, M Lenoci, D Rondelli, N Testoni, G Nardi… - Leukemia, 2001 - nature.com
Abstract CD56 antigen, a 200–220 kDa cell surface glycoprotein, identified as an isoform of
the neural adhesion molecules (NCAM), has been found frequently expressed in several …
被引用次数：222 相关文章

[引用][C] CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis

D RASPADORI, D DAMIANI, F LAURIA, M LENOCI… - …, 2001 - pascal-francis.inist.fr
CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical
prognosis CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
[PDF] academia.edu

[PDF][PDF] CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis

D Raspadori, D Damiani, M Lenoci, D Rondelli… - Leukemia, 2001 - academia.edu
Acute myeloid leukemias (AML) could be considered as a heterogeneous group of disorders
which often present with different morphological, immunophenotypic and cytogenetic …

CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis

D Raspadori, D Damiani, M Lenoci, D Rondelli… - Leukemia, 2001 - go.gale.com
CD56 antigen, a 200-220 kDa cell surface glycoprotein, identified as an isoform of the
neural adhesion molecules (NCAM), has been found frequently expressed in several …

CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis

D Raspadori, D Damiani, M Lenoci, D Rondelli… - …, 2001 - pubmed.ncbi.nlm.nih.gov
CD56 antigen, a 200-220 kDa cell surface glycoprotein, identified as an isoform of the
neural adhesion molecules (NCAM), has been found frequently expressed in several …

[引用][C] CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis”.

D Raspadori, D Damiani, M Lenoci, D Rondelli… - LEUKEMIA, 2001 - air.uniud.it
CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical
prognosis”. IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT …

CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis.

D Raspadori, D Damiani, M Lenoci, D Rondelli… - Leukemia, 2001 - europepmc.org
CD56 antigen, a 200-220 kDa cell surface glycoprotein, identified as an isoform of the
neural adhesion molecules (NCAM), has been found frequently expressed in several …

[引用][C] CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis

D Raspadori, D Damiani, M Lenoci, D Rondelli… - Leukemia, 2001 - cir.nii.ac.jp

CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis.

D Raspadori, D Damiani, M Lenoci… - Leukemia …, 2001 - search.ebscohost.com
Abstract CD56 antigen, a 200-220 kDa cell surface glycoprotein, identified as an isoform of
the neural adhesion molecules (NCAM), has been found frequently expressed in several …
[PDF] researchgate.net

[PDF][PDF] CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis

D Raspadori, D Damiani, M Lenoci, D Rondelli… - Leukemia, 2001 - researchgate.net
Acute myeloid leukemias (AML) could be considered as a heterogeneous group of disorders
which often present with different morphological, immunophenotypic and cytogenetic …